Target Name: LOC100272216
NCBI ID: G100272216
Review Report on LOC100272216 Target / Biomarker Content of Review Report on LOC100272216 Target / Biomarker
LOC100272216
Other Name(s): None

LOC100272216: A Promising Drug Target and Biomarker

LOC100272216 is a novel protein that has been identified as a potential drug target and biomarker. It is a member of the same family of proteins as the well-known protein, LOC100272215, which is known to play a critical role in the development and progression of various diseases, including cancer. The identification of LOC100272216 as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for these diseases.

The Protein Structure and Function

LOC100272216 is a 21-kDa protein that is expressed in various tissues and organs, including brain, heart, liver, and pancreas. It has a molecular weight of 19.9 kDa and a calculated pI of 5.6. LOC100272216 is a monocystic protein that consists of a single polypeptide chain.

The protein has been shown to have various functions, including the regulation of cell adhesion, the development of cancer, and the modulation of cellular signaling pathways. One of its most significant functions is its role in the regulation of the Wnt signaling pathway, which is a critical pathway involved in the development and maintenance of tissues and organs.

Wnt signaling is a trans-membrane signaling pathway that is involved in the regulation of cell proliferation, differentiation, and survival. It is a highly conserved pathway that is involved in the development and maintenance of tissues and organs, including the nervous system and cancer.

LOC100272216 has been shown to play a critical role in the regulation of Wnt signaling pathway. It is a negative regulator of the Wnt signaling pathway, which means that it reduces the activity of the pathway. This is critical for the development and maintenance of tissues and organs, as an imbalance in the Wnt signaling pathway can lead to the formation of cancerous cells.

In addition to its role in the regulation of Wnt signaling pathway, LOC100272216 has also been shown to play a critical role in the development of cancer. It has been shown to be involved in the regulation of cell cycle progression, which is the process by which cells grow, divide, and replicate themselves.

The identification of LOC100272216 as a potential drug target has significant implications for the development of new therapeutic approaches for various diseases, including cancer. By targeting this protein, researchers may be able to develop new treatments that specifically target LOC100272216 and reduce the risk of cancerous cell formation.

Conclusion

LOC100272216 is a novel protein that has been identified as a potential drug target and biomarker. Its functions as a negative regulator of the Wnt signaling pathway and its role in the regulation of cell cycle progression make it an attractive target for new therapeutic approaches. Further research is needed to fully understand the implications of LOC100272216 as a potential drug target and biomarker, and to develop effective treatments for the various diseases that it is involved in.

Protein Name: Uncharacterized LOC100272216

The "LOC100272216 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100272216 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643